Giving aspirin and ibuprofen after myocardial infarction
Abstract
Footnotes Competing interests SEK has received funding for research from companies that manufacture non-steroidal anti-inflammatory drugs and has served as a consultant for Bayer Consumer Care. BLS has received research funding from and been a consultant to most manufacturers of non-steroidal anti-inflammatory drugs.Keywords
This publication has 13 references indexed in Scilit:
- Aspirin, ibuprofen, and mortality after myocardial infarction: retrospective cohort studyBMJ, 2003
- Inhibition of Clinical Benefits of Aspirin on First Myocardial Infarction by Nonsteroidal Antiinflammatory DrugsCirculation, 2003
- Frequency of use of acetaminophen, nonsteroidal anti‐inflammatory drugs, and aspirin in US womenPharmacoepidemiology and Drug Safety, 2002
- Aspirin for Primary Prevention of Coronary EventsNew England Journal of Medicine, 2002
- Cyclooxygenase Inhibitors and the Antiplatelet Effects of AspirinNew England Journal of Medicine, 2001
- Exploring the Link between Gastrointestinal Complications and Over-the-Counter AnalgesicsAmerican Journal of Therapeutics, 2000
- Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) studyJournal Of Hypertension, 1999
- Adherence to Aspirin in the Prevention of Myocardial InfarctionArchives of internal medicine (1960), 1994
- Aspirin as an Antiplatelet DrugNew England Journal of Medicine, 1994
- Striking Prevalence of Over-the-Counter Nonsteroidal Anti-inflammatory Drug Use in Patients With Upper Gastrointestinal HemorrhageArchives of internal medicine (1960), 1994